The story
YourHealthRx was built around one question: what would peptide medicine look like if it behaved like medicine — with screening, clinician review, quality sourcing, and real follow-up?
Too much of the category pretends peptides are supplements. The rest gates them so tightly only a handful of boutique practices even engage. We're building the middle: science-forward education, careful clinical review, and a follow-up model that treats therapy as longitudinal, not transactional.
Educational content should explain mechanism, evidence strength, uncertainty, and practical screening requirements — not hype.
Users should feel informed and in control, while medical decisions remain with licensed clinicians.
Quality messaging emphasizes pharmacy standards, documentation, and transparency — without overpromising.
Principles
Principles are how we evaluate trade-offs when the easy answer is to cut a corner.
Design can be beautiful, but the underlying experience has to act like medicine — not a storefront.
Every pathway is an educational blueprint first. Prescriptions follow clinician review, not a button press.
What happens after intake matters more than what happens during it. Monitoring is built in, not bolted on.
Pharmacy partners are selected for quality and documentation, and we speak plainly about what we know.
Not every compound or pathway is available in every state. We don't pretend otherwise.
Where evidence is thin, we say so. Patients deserve to know what's well-studied and what isn't.
FAQ
These are the friction points — quality, eligibility, cost, privacy, and what happens after intake. Clear answers belong up front.
Prescriptions are routed through qualified pharmacy partners with documented quality controls. We speak openly about sourcing and standards in plain language.
Some pathways can begin with intake alone; others require — or strongly benefit from — biomarker context. Your clinician decides what's appropriate.
Peptide therapy is often cash-pay. FDA-approved medications used in some pathways may have different coverage possibilities.
No. Eligibility, prescribing, dosage, and follow-up are determined by licensed clinicians. Not every pathway is available in every state, and not every patient is a candidate.
Health information is handled through secure partner workflows designed to protect privacy and support HIPAA compliance. Sensitive clinical intake data is collected by licensed providers, not by YourHealthRx directly.
Cycling off, pausing, or stopping is a clinical decision, and your clinician is there for it. Adherence includes knowing when to stop, not just when to continue.
Informational only. Content on this page is for informational purposes and does not constitute medical advice. All prescriptions are issued at the sole discretion of the prescribing clinician. Peptide compounds are prescribed for licensed therapeutic indications only. Not all compounds are available in all states. Results vary.
Ready to talk?
Science-forward, clinician-led, and follow-up first.